I. Stobbe

Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data.

D. Roelen, I. Doxiadis, K. Wood, 2001, Human immunology.

In vitro CTL precursor frequencies do not reflect a beneficial effect of cross-reactive group (CREG) matching.

I. Doxiadis, M. Oudshoorn, F. Claas, 2000, Human immunology.

Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.

I. Doxiadis, J. D. De Meester, M. Oudshoorn, 2000, Transplantation.

In vitro reactivity of allospecific cytotoxic T lymphocytes does not explain the taboo phenomenon.

F. Claas, J. Smits, I. Stobbe, 1999, Transplant immunology.

Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.

Å. Lernmark, F. Claas, D. Pipeleers, 1999, Diabetes.

Tolerance to kidney allograft transplanted into Type I diabetic patients persists after in vivo challenge with pancreatic islet allografts that express repeated mismatches

Å. Lernmark, D. Pipeleers, B. Roep, 1999, Diabetologia.

Beneficial and detrimental human leucocyte antigen (HLA)-DR mismatches are not reflected by a differential effect of immunosuppressive drugs on the in vitro alloimmune response.

F. Claas, E. van Beelen, I. Stobbe, 1999, Transplant immunology.

Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.

H. V. van Houwelingen, F. Claas, J. Smits, 1996, Transplantation proceedings.